Share
Sitemap
- Authorisation and supervision
- Medicines and other products
- Company authorisations
- Licensing of medicines
- Case statistics and order books
- Marketing authorisation
- Request for scientific advice
- Application for marketing authorisation
- Time slots for DCP procedures with Denmark as Reference Member State
- Validation of applications
- Updating of documentation prior to initiation of MRP
- Procedure for national applications
- Sunset clause - initiation or cessation of marketing
- Paediatric data
- Parallel import
- Parallel distribution
- Variations
- Renewal of marketing authorisation
- Deregistration
- Summaries of product characteristics, package leaflets and labelling
- Naming of medicines
- Lists of authorised and deregistered medicines
- The Licensing Committee
- Fees
- Supervision and inspection
- Compassionate use permits
- Export certificates
- Companies' name and address changes
- Side effects and trials
- Side effects
- Report a side effect or incident
- Registration and monitoring
- Companies' reporting of side effects
- Positive experience with ADR reporting
- Drug Analysis Prints: reported adverse reactions
- Medicines with stricter reporting requirements for doctors, dentists and veterinarians
- Compensation
- The Council for Adverse Drug Reactions
- The EU Pharmacovigilance Working Party (PhVWP)
- Safety updates
- Adverse incidents
- Clinical trials
- Drug interaction databases
- Side effects
- Retail and online sale
- Pharmacies
- Sale outside pharmacies
- Over-the-counter medicines
- Medicines on the internet
- Importing medicines to Denmark
- Counterfeit medicines
- Statistics, prices and reimbursement
- Statistics and analyses
- Prices of medicines
- Product numbers
- Reimbursement
- Substitution
- Temaer
- News
- Product areas
- Product information
- Legislation
- About us
- Contact us
- Themes
- Publications
- Sitemap
